You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

fluoromisonidazole

Showing 26 - 50 of 50
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC Trial in United States (Erlotinib, Hydroxychloroquine)

Unknown status
Has Results
  • Non-small Cell Lung Cancer
  • Stanford, California
  • +3 more
Jul 1, 2020

NSCLC Trial in Oxford (Atovaquone)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • Oxford, Oxfordshire, United Kingdom
    Churchill Hospital
Sep 2, 2019

Metastatic Osteosarcoma Trial in Baltimore (drug, other, radiation)

Terminated
Has Results
  • Metastatic Osteosarcoma
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Oct 11, 2019

Liver Cancer, Liver Tumor, Hepatocellular Carcinoma Trial run by the CC ([18F] FMISO)

Completed
Has Results
  • Liver Cancer
  • +3 more
  • [18F] FMISO
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 29, 2019

Cervical Adenocarcinoma, Cervical Squamous Cell Carcinoma, Stage IB Cervical Cancer Trial in Seattle (other, radiation,

Completed
Has Results
  • Cervical Adenocarcinoma
  • +7 more
  • 18F-fluoromisonidazole
  • +3 more
  • Seattle, Washington
    University of Washington Medical Center
Dec 28, 2016

Chordoma Trial in Boston (Fluoromisonidazole-PET/CT)

Completed
  • Chordoma
  • Fluoromisonidazole-PET/CT
  • Boston, Massachusetts
    Massachusetts General Hospital
Feb 2, 2017

Melanoma, Skin Cancer Trial (Pimonidazole HCl (Hypoxyprobe™-1), Optional 18F-FMISO PET scan (18F-fluoromisonidazole), Surgical

Withdrawn
  • Melanoma
  • Skin Cancer
  • Pimonidazole hydrochloride (Hypoxyprobe™-1)
  • +2 more
  • (no location specified)
May 6, 2016

Cancer of Head and Neck, Head and Neck Tumors Trial in Bordeaux, Villenave D Ornon (Positon Emission Tomography using 18F-FMISO)

Completed
  • Cancer of Head and Neck
  • Head and Neck Neoplasms
  • Positon Emission Tomography using 18F-FMISO
  • Bordeaux, France
  • +1 more
Aug 8, 2017

Prostate Adenocarcinoma Trial in Poitiers, St Herblain (18-F-MISO)

Completed
  • Prostate Adenocarcinoma
  • Poitiers, France
  • +1 more
Nov 6, 2015

Hypoxia in Rectal Cancer Trial in Oxford (Pimonidazole, F-MISO PET, pCT)

Completed
  • Hypoxia in Rectal Cancer
  • Pimonidazole
  • +5 more
  • Oxford, United Kingdom
    Oxford University Hospitals NHS Trust
Mar 8, 2017

Ischemic Stroke Trial (PET and MRI)

Withdrawn
  • Ischemic Stroke
  • PET and MRI
  • (no location specified)
May 6, 2016

Hypoxia Imaging -Guided Radiotherapy of Nasopharyngeal Carcinoma

Unknown status
  • Nasopharyngeal Carcinoma
  • FMISO-PET/CT
  • +2 more
  • (no location specified)
Mar 13, 2014

Squamous Cell Carcinoma of the Head and Neck Trial in Tuebingen (radiochemo with 70 Gy, radiochemo with 77 Gy)

Recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • radiochemotherapy with 70 Gy
  • radiochemotherapy with 77 Gy
  • Tuebingen, Baden-Württemberg, Germany
    Tuebingen university, radiation oncology
Jan 30, 2015

Breast Cancer, Colorectal Cancer, Esophageal Cancer Trial in London (other, procedure, radiation)

Unknown status
  • Breast Cancer
  • +4 more
  • 18F-fluoromisonidazole
  • +8 more
  • London, England, United Kingdom
    University College Hospital
Aug 23, 2013

Glioblastoma Trial in Bordeaux (18F]-FMISO PET-CT)

Completed
  • Glioblastoma
  • 18F]-FMISO PET-CT
  • Bordeaux, France
    CHU de Bordeaux - Hôpital Pellegrin
Feb 27, 2013

Breast Tumors Trial in Spain (Bevacizumab, docetaxel and doxorubicin followed by surgery)

Completed
  • Breast Neoplasms
  • Bevacizumab, docetaxel and doxorubicin followed by surgery
  • Teruel, Aragón, Spain
  • +10 more
Sep 9, 2013

Squamous Cell Carcinoma, Head and Neck Tumors, Metastases, Tumor Trial in Houston (18F-fluoromisonidazole, PET scan)

Withdrawn
  • Squamous Cell Carcinoma
  • +2 more
  • Houston, Texas
    University of Texas M. D. Anderson Cancer Center
Jul 31, 2012

NSCLC Trial in Heidelberg (Multimodal hypoxia imaging)

Terminated
  • Non-small Cell Lung Cancer
  • Multimodal hypoxia imaging
  • Heidelberg, Baden-Württemberg, Germany
    German Cancer Research Center
Mar 14, 2014

Breast Cancer, Hypoxia Trial in Shanghai (18FMISO PET/CT scan, Letrozole)

Unknown status
  • Breast Cancer
  • Hypoxia
  • Shanghai, Shanghai, China
    Cancer Hospital/ Institute, Fudan University
Mar 19, 2013

Lung Cancer Trial in United States (PR104, F-18-fluoromisonidazole)

Terminated
Has Results
  • Lung Cancer
  • PR104
  • F-18-fluoromisonidazole
  • Tucson, Arizona
  • +17 more
Dec 6, 2012

NSCLC Trial in Canada, New Zealand, United States (PR104, docetaxel, Granulocyte colony-stimulating factor)

Terminated
Has Results
  • Non-Small Cell Lung Cancer
  • San Diego, California
  • +26 more
Jan 8, 2013

Head Neck Cancer, Lung Cancer, Liver Cancer Trial in Shanghai ([F-18] FMISO, [F-18] HX4)

Completed
  • Head and Neck Cancer
  • +2 more
  • [F-18] FMISO
  • [F-18] HX4
  • Shanghai, China
    PET Center, Huashan Hospital, Fudan University
Sep 20, 2012

Solid Tumor Trial in Scottsdale, San Antonio, Hamilton (biological, drug, other)

Completed
  • Unspecified Adult Solid Tumor, Protocol Specific
  • filgrastim
  • +2 more
  • Scottsdale, Arizona
  • +2 more
May 31, 2011

Solid Tumor Trial in San Diego, Auckland, Hamilton (PR-104, docetaxel, gemcitabine HCl)

Completed
  • Unspecified Adult Solid Tumor, Protocol Specific
  • San Diego, California
  • +2 more
Feb 28, 2011

Hypoxia Imaging With 18F FAZA. Prognostic Impact in Cervical

Unknown status
  • Uterine Cervical Neoplasms
  • 18F Fluoroazomycin Arabinoside (FAZA)
  • Vienna, Austria
  • +1 more
Oct 16, 2006